BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11458270)

  • 1. Angiogenesis-dependent diseases and angiogenesis therapy.
    Tímár J; Döme B; Fazekas K; Janovics A; Paku S
    Pathol Oncol Res; 2001; 7(2):85-94. PubMed ID: 11458270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor as a target for antiangiogenic therapy.
    Gordon MS
    J Clin Oncol; 2000 Nov; 18(21 Suppl):45S-6S. PubMed ID: 11060326
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?].
    Joussen AM; Kirchhof B; Gottstein C
    Ophthalmologe; 2003 Apr; 100(4):284-91. PubMed ID: 12682760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vessels of death or life.
    Jain RK; Carmeliet PF
    Sci Am; 2001 Dec; 285(6):38-45. PubMed ID: 11759584
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors].
    Werther K; Nielsen HJ
    Ugeskr Laeger; 2000 Sep; 162(37):4916-20. PubMed ID: 11002739
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
    Sgadari C; Barillari G; Toschi E; Carlei D; Bacigalupo I; Baccarini S; Palladino C; Leone P; Bugarini R; Malavasi L; Cafaro A; Falchi M; Valdembri D; Rezza G; Bussolino F; Monini P; Ensoli B
    Nat Med; 2002 Mar; 8(3):225-32. PubMed ID: 11875492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
    Ferrara N
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.
    Bikfalvi A; Bicknell R
    Trends Pharmacol Sci; 2002 Dec; 23(12):576-82. PubMed ID: 12457776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
    Rafii S; Lyden D; Benezra R; Hattori K; Heissig B
    Nat Rev Cancer; 2002 Nov; 2(11):826-35. PubMed ID: 12415253
    [No Abstract]   [Full Text] [Related]  

  • 12. VEGF receptor signaling in tumor angiogenesis.
    McMahon G
    Oncologist; 2000; 5 Suppl 1():3-10. PubMed ID: 10804084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis in cancer and other diseases.
    Carmeliet P; Jain RK
    Nature; 2000 Sep; 407(6801):249-57. PubMed ID: 11001068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological basis for anti-angiogenic therapy, 8-10 November 1999, Milan, Italy.
    Meade-Tollin LC
    Acta Histochem; 2000 May; 102(2):117-27. PubMed ID: 10824605
    [No Abstract]   [Full Text] [Related]  

  • 15. Promises and pitfalls of anti-angiogenic therapy in clinical trials.
    McCarty MF; Liu W; Fan F; Parikh A; Reimuth N; Stoeltzing O; Ellis LM
    Trends Mol Med; 2003 Feb; 9(2):53-8. PubMed ID: 12615038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can mosaic tumor vessels facilitate molecular diagnosis of cancer?
    Folkman J
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):398-400. PubMed ID: 11209044
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
    Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
    J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological basis for antiangiogenic therapy.
    Giavazzi R; Albini A; Bussolino F; DeBraud F; Presta M; Ziche M; Costa A
    Eur J Cancer; 2000 Oct; 36(15):1913-8. PubMed ID: 11000570
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.
    Brown LF; Detmar M; Claffey K; Nagy JA; Feng D; Dvorak AM; Dvorak HF
    EXS; 1997; 79():233-69. PubMed ID: 9002222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.